ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
- Net income, 2025
- $314M
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $314M | — |
| 2024 | −$278M | — |
| 2023 | −$440M | — |
| 2022 | −$1.1B | — |
| 2021 | −$853M | — |
| 2020 | −$858M | — |
| 2019 | −$886M | — |
| 2018 | −$761M | — |
| 2017 | −$491M | — |
| 2016 | −$410M | — |
| 2015 | −$290M | — |
| 2014 | −$360M | — |
| 2013 | −$89M | — |
| 2012 | −$106M | — |
| 2011 | −$58M | — |
| 2010 | −$44M | — |
| 2009 | −$48M | — |
| 2008 | −$26M | — |